4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000011
Chief Medical Officer sold 20,404 shares at an average $27.93 ($569,809)
- Chief Medical Officer acquired 14,056 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-02-12 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 56,786 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-12 | Sale 10b5-1 | −5,828 | $28.94 | $168,635 | 50,958 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-12 | Sale 10b5-1 | −521 | $29.64 | $15,442 | 50,437 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Option exercise 10b5-1 | +3,541 | $10.20 | $36,118 | 53,978 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Sale 10b5-1 | −3,541 | $27.33 | $96,776 | 50,437 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Option exercise 10b5-1 | +4,166 | $14.25 | $59,366 | 54,603 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Sale 10b5-1 | −4,166 | $27.33 | $113,857 | 50,437 | D |
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Sale 10b5-1 | −6,348 | $27.58 | $175,100 | 44,089 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-02-12 | Option exercise · Stock Option 10b5-1 | −6,349 | 31,743 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Option exercise · Stock Option 10b5-1 | −3,541 | 127,501 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-02-13 | Option exercise · Stock Option 10b5-1 | −4,166 | 100,001 | D | ||
| Open-market sales · 20,404 sh · avg $27.93 · $569,809 | |||||||
Loading xslF345X05/wk-form4_1771028714.xml…